Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure

伤亡人数 Toll样受体 肝衰竭 医学 重症监护医学 内科学 免疫学 受体 先天免疫系统
作者
Cornelius Engelmann,Mohammed Sheikh,Shreya Sharma,Takayuki Kondo,Henry Loeffler‐Wirth,Yu Bao Zheng,Simone Novelli,Andrew Rennie Hall,Annarein J. C. Kerbert,Jane Macnaughtan,Rajeshwar P. Mookerjee,Abeba Habtesion,Nathan A. Davies,Tauhid Ali,Saurabh Gupta,Fausto Andreola,Rajiv Jalan
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:73 (1): 102-112 被引量:187
标识
DOI:10.1016/j.jhep.2020.01.011
摘要

Toll-like receptor 4 (TLR4) plays an essential role in mediating organ injury in acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). Herein, we assess whether inhibiting TLR4 signaling can ameliorate liver failure and serve as a potential treatment.Circulating TLR4 ligands and hepatic TLR4 expression were measured in plasma samples and liver biopsies from patients with cirrhosis. TAK-242 (TLR4 inhibitor) was tested in vivo (10 mg/kg intraperitoneally) in rodent models of ACLF (bile duct ligation + lipopolysaccharide [LPS]; carbon tetrachloride + LPS) and ALF (galactosamine + LPS) and in vitro on immortalized human monocytes (THP-1) and hepatocytes (HHL5). The in vivo therapeutic effect was assessed by coma-free survival, organ injury and cytokine release and in vitro by measuring IL-6, IL-1β or cell injury (TUNEL), respectively.In patients with cirrhosis, hepatic TLR4 expression was upregulated and circulating TLR4 ligands were increased (p <0.001). ACLF in rodents was associated with a switch from apoptotic cell death in ALF to non-apoptotic forms of cell death. TAK-242 reduced LPS-induced cytokine secretion and cell death (p = 0.002) in hepatocytes and monocytes in vitro. In rodent models of ACLF, TAK-242 administration improved coma-free survival, reduced the degree of hepatocyte cell death in the liver (p <0.001) and kidneys (p = 0.048) and reduced circulating cytokine levels (IL-1β, p <0.001). In a rodent model of ALF, TAK-242 prevented organ injury (p <0.001) and systemic inflammation (IL-1β, p <0.001).This study shows that TLR4 signaling is a key factor in the development of both ACLF and ALF; its inhibition reduces the severity of organ injury and improves outcome. TAK-242 may be of therapeutic relevance in patients with liver failure.Toll-like receptor 4 (or TLR4) mediates endotoxin-induced tissue injury in liver failure and cirrhosis. This receptor sensitizes cells to endotoxins, which are produced by gram-negative bacteria. Thus, inhibiting TLR4 signaling with an inhibitor (TAK-242) ameliorates organ injury and systemic inflammation in rodent models of acute and acute-on-chronic liver failure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
章绝施完成签到,获得积分10
2秒前
2秒前
经十路以东完成签到,获得积分10
2秒前
科研通AI6.4的应助被张张张采纳,获得10
3秒前
4秒前
蛋蛋子完成签到,获得积分10
4秒前
椰不许卷发布了新的文献求助10
4秒前
在水一方的应助被萧小五采纳,获得10
4秒前
瑾钰满糖完成签到,获得积分10
5秒前
锦2004发布了新的文献求助10
5秒前
一昂完成签到 ,获得积分10
5秒前
荀彧发布了新的文献求助10
6秒前
6秒前
不想活了发布了新的文献求助10
8秒前
限量版小祸害完成签到 ,获得积分10
9秒前
愤怒的店员完成签到,获得积分10
9秒前
失眠的数据线完成签到,获得积分10
10秒前
酷波er的应助被科研战士采纳,获得30
10秒前
11秒前
12秒前
曹思佳完成签到 ,获得积分10
12秒前
12秒前
12秒前
13秒前
热情怡完成签到 ,获得积分10
15秒前
gg棒完成签到 ,获得积分10
16秒前
16秒前
16秒前
研友_ndv5j8发布了新的文献求助10
16秒前
Ava的应助被18756828852采纳,获得10
16秒前
JamesPei的应助被MoreScholarship采纳,获得10
17秒前
zdy发布了新的文献求助10
18秒前
Frank发布了新的文献求助10
18秒前
蹬蹬蹬完成签到,获得积分10
18秒前
实验大牛完成签到,获得积分10
18秒前
19秒前
深情安青的应助被好大个橘子采纳,获得10
20秒前
一昂关注了科研通微信公众号
20秒前
kevin完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192548
求助须知:如何正确求助?哪些是违规求助? 9579054
关于积分的说明 21863359
捐赠科研通 7792096
什么是DOI,文献DOI怎么找? 3436955
关于科研通互助平台的介绍 2560622
邀请新用户注册赠送积分活动 2483860